Locations:
Search IconSearch
September 23, 2015/Primary Care/News & Insights

High-risk Anticoagulation Patients: A Conversation with Oussama Wazni, MD, and Walid Saliba, MD

New options for patients who can’t take anticoagulants

Anticoagulation-690×380

Co-Directors of Cleveland Clinic’s High-risk Anticoagulation Clinic, Oussama Wazni, MD, and Walid Saliba, MD, explain the proper approach to treating patients resistant to traditional anticoagulant medications.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Whom should PCPs refer to the High-risk Anticoagulation Clinic?

Any patients who have atrial fibrillation with a history of bleeding (whether in the stomach, intestines or brain) who cannot take traditional anticoagulant medications are appropriate to refer to our clinic. Effectively reducing their stroke risk is still possible.

Why is a multidisciplinary approach key for this patient population?

Today, new medications and procedures are available to help patients who cannot take traditional anticoagulants.

Cleveland Clinic’s Sydell and Arnold Miller Family Heart & Vascular Institute has combined specialists in electrophysiology, vascular medicine, gastroenterology and neurovascular medicine to provide a multidisciplinary approach to reducing stroke risk. Our High-risk Anticoagulation Clinic team will work together with your patients to assess their risk of stroke and bleeding and create an individualized care plan that best meets their needs.

In addition to the electrophysiology specialists, our team includes John Bartholomew, MD (Vascular Medicine); Sunguk Jang, MD, and Chung-Jyi Tsai, MD, PhD (Gastroenterology and Hepatology); and Muhammad Shazam Hussain, MD (Neurovascular Medicine).

What can patients expect?

Based on their medical history, patients will have specialized blood work and imaging tests (electrocardiogram, comprehensive transthoracic echo, transesophageal echo, cardiac MR and multidetector CT scanning, EGD).

They will meet with a cardiologist from the High-risk Anticoagulation Clinic, who will review their records and medical history, perform a physical examination, review their test results, and provide them with an assessment and plan. If patients need to meet with one of the other multidisciplinary specialists, they will be consulted in one to two days.

Advertisement

You can refer patients to the High-risk Anticoagulation Clinic by calling 216.444.0400.

Advertisement

Related Articles

Osteopathic practitioner manipulating patient's face
Case: Osteopathic Manipulative Treatment Provides Eye-Symptom Relief

OMT may be right for some with Graves’ eye disease

Photo of patient injecting drug into stomach
February 22, 2024/Primary Care/Research
Cleveland Clinic Study Identifies Factors Associated With Long-Term Use of Popular Anti-Obesity Medications

Perserverance may depend on several specifics, including medication type, insurance coverage and medium-term weight loss

Global Healthcare
July 28, 2023/Primary Care
How Does Climate Change Impact Our Patients?

Integrate climate-related health information and counseling into your practice

21-URL-2535162 – CQD 650×450
December 27, 2021/Primary Care
1-Minute Consult: Can a PICC Be Placed in a Patient With Chronic Kidney Disease?

Physicians discuss a specific case example, and PICC pros, cons and alternatives

Asthma
November 9, 2021/Primary Care
Outpatient Management of Asthma in Adults

A snapshot of the 2020 GINA report

21-PUL-2475558 The Current State of Tobacco Cessation_CQD
November 5, 2021/Primary Care
Pharmacological Approaches to Tobacco Cessation

A review of available interventions

Chest x-ray adolescent vaping injury
November 3, 2021/Primary Care
The Current State of Tobacco Cessation: E-Cigarettes

Abstinence from combustibles, dependence on vaping

Ad